|
|||||
|
|
The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus |
|
| Authors: | Veerle van Hulten MSc Johanna H. M. Driessen PhD Jakob K. Starup-Linde PhD Zheer K. Al-Mashhadi MD Rikke Viggers MD Olaf H. Klungel PhD Patrick C. Souverein PhD Peter Vestergaard MD Coen D. A. Stehouwer MD Joop P. van den Bergh MD |
| Affiliation: | 1. Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands;2. Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands;3. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark;4. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;5. Steno Diabetes Center North Denmark, Aalborg, Denmark Department of Clinical Medicine, Aalborg University, Aalborg, Denmark;6. Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands;7. Steno Diabetes Center North Denmark, Aalborg, Denmark Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark;8. Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre+ (MUMC+), Maastricht, Netherlands;9. School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands Department of Internal Medicine, Subdivision of Endocrinology, VieCuri Medical Center, Venlo, The Netherlands |
| Abstract: | |
| Keywords: | cohort study diabetes complications DPP-4 inhibitor pharmacoepidemiology SGLT2 inhibitor type 2 diabetes |